Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Assets (2016 - 2025)

Traws Pharma's Return on Assets history spans 13 years, with the latest figure at 1.55% for Q4 2025.

  • Quarterly results put Return on Assets at 1.55% for Q4 2025, up 685.0% from a year ago — trailing twelve months through Dec 2025 was 1.55% (up 685.0% YoY), and the annual figure for FY2025 was 1.0%, up 497.0%.
  • Return on Assets for Q4 2025 was 1.55% at Traws Pharma, down from 1.12% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.29% in Q4 2021 to a low of 10.25% in Q3 2024.
  • The 5-year median for Return on Assets is 0.72% (2023), against an average of 2.18%.
  • The sharpest move saw Return on Assets tumbled -950bps in 2024, then surged 912bps in 2025.
  • Year by year, Return on Assets stood at 0.29% in 2021, then plummeted by -65bps to 0.47% in 2022, then plummeted by -73bps to 0.82% in 2023, then crashed by -929bps to 8.4% in 2024, then soared by 82bps to 1.55% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 1.55%, 1.12%, and 1.17% for Q4 2025, Q3 2025, and Q2 2025 respectively.